Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Natural History of Human Papillomavirus From Infection to Neoplasia
IV Mntx Gut Effect in Chronic Methadone Therapy and Chronic Pain Patients
Outcomes Committee Agenda
Mutations in X-Linked Chronic Granulomatous Disease;Gene Amplification
Renovation of Research Laboratories in Higgins Laboratory Building
Recently added grants:
Treatments Against RA and Effect on FDG PET CT: The TARGET TRIAL
Mitochondrial metabolism and bone formation
Targeting the CHRNA7 Receptor to Modulate Wound Antimicrobial Responses
Mouse models to discover new drivers of medulloblastoma
Academic-Industrial Partnership for Translation of Pet/Trus Guided Intervention
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-001
Application #
6994841
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant